Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1998-9-21
pubmed:abstractText
To assess the efficacy, safety, and tolerability of acarbose versus placebo during a 24-week treatment period in Asian type 2 diabetic patients with dietary failure.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0149-5992
pubmed:author
pubmed:issnType
Print
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1058-61
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9653595-Acarbose, pubmed-meshheading:9653595-Adult, pubmed-meshheading:9653595-Asia, pubmed-meshheading:9653595-Blood Glucose, pubmed-meshheading:9653595-Body Weight, pubmed-meshheading:9653595-Diabetes Mellitus, Type 2, pubmed-meshheading:9653595-Diabetic Diet, pubmed-meshheading:9653595-Dietary Carbohydrates, pubmed-meshheading:9653595-Double-Blind Method, pubmed-meshheading:9653595-Eating, pubmed-meshheading:9653595-Fasting, pubmed-meshheading:9653595-Female, pubmed-meshheading:9653595-Flatulence, pubmed-meshheading:9653595-Hemoglobin A, Glycosylated, pubmed-meshheading:9653595-Humans, pubmed-meshheading:9653595-Hypoglycemic Agents, pubmed-meshheading:9653595-Male, pubmed-meshheading:9653595-Middle Aged, pubmed-meshheading:9653595-Patient Dropouts, pubmed-meshheading:9653595-Postprandial Period, pubmed-meshheading:9653595-Treatment Outcome, pubmed-meshheading:9653595-Trisaccharides
pubmed:year
1998
pubmed:articleTitle
An Asian multicenter clinical trial to assess the efficacy and tolerability of acarbose compared with placebo in type 2 diabetic patients previously treated with diet. Asian Acarbose Study Group.
pubmed:affiliation
Department of Clinical Pharmacology, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, China. jchan@cuhk.edu.hk
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study